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Abstract
Sensitization and exposure to the allergenic fungus Alternaria alternata has been associated with increased risk of asthma
and asthma exacerbations. The first cells to encounter inhaled allergens are epithelial cells at the airway mucosal surface.
Epithelial barrier function has previously been reported to be defective in asthma. This study investigated the contribution
of proteases from Alternaria alternata on epithelial barrier function and inflammatory responses and compared responses of
in vitro cultures of differentiated bronchial epithelial cells derived from severely asthmatic donors with those from non-
asthmatic controls. Polarised 16HBE cells or air-liquid interface (ALI) bronchial epithelial cultures from non-asthmatic or
severe asthmatic donors were challenged apically with extracts of Alternaria and changes in inflammatory cytokine release
and transepithelial electrical resistance (TER) were measured. Protease activity in Alternaria extracts was characterised and
the effect of selectively inhibiting protease activity on epithelial responses was examined using protease inhibitors and
heat-treatment. In 16HBE cells, Alternaria extracts stimulated release of IL-8 and TNFa, with concomitant reduction in TER;
these effects were prevented by heat-treatment of the extracts. Examination of the effects of protease inhibitors suggested
that serine proteases were the predominant class of proteases mediating these effects. ALI cultures from asthmatic donors
exhibited a reduced IL-8 response to Alternaria relative to those from healthy controls, while neither responded with
increased thymic stromal lymphopoietin (TSLP) release. Only cultures from asthmatic donors were susceptible to the barrier-
weakening effects of Alternaria. Therefore, the bronchial epithelium of severely asthmatic individuals may be more
susceptible to the deleterious effects of Alternaria.
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Introduction
Asthma is a chronic inflammatory airways disease that is
characterised physiologically by airway hyperresponsiveness to
innocuous stimuli, and pathologically by Th2 inflammation and
structural remodelling of the airways. The majority of asthma is
associated with atopy, where an IgE response to specific aeroaller-
gens has developed. The airway epithelium which forms both a
physical barrier and an interface with the immune system via
expression of adhesion molecules and secretion of a myriad
cytokines, chemokines, and inflammatory mediators [1–3], is the
first tissue encountered by such inhaled allergens. However, recent
evidence has suggested that the asthmatic bronchial epithelium is
structurally perturbed, resulting in impairment of barrier function
[4].
Allergens from fungi including species of Alternaria, Cladosporium,
and Aspergillus present a major risk factor for the development of
asthma, with evidence supporting a link between sensitisation to
fungi and prevalence or severity of asthma [5,6], and also between
spore prevalence and asthma [7,8]. Further reports have found
links between sensitivity to the common Alternaria species of fungi,
particularly Alternaria alternata, and asthma [7,9–12]. Pathogenic
fungi secrete a range of proteases [13], with those of the serine
class being particularly associated with asthma [14]. In vitro studies
have shown that serine proteases from Aspergillus fumigatus and
Alternaria alternata induce production of IL-8 and IL-6, as well as
causing epithelial cell detachment [15–17]. This action is reported
to occur via activation of protease activated receptor (PAR)22
[18,19], which has been observed to be up-regulated in the
bronchial epithelium of asthmatic subjects [20], and can be
replicated by use of a synthetic PAR-2 activating peptide [21].
Similar effects have been seen with the house dust mite (HDM)
cysteine and serine protease allergens Der p 1 and Der p 3 [18,22],
and also serine proteases from German cockroach extract [23].
Alternaria-induced PAR-2 cleavage has also been suggested to be
responsible for TSLP release from epithelial cells, and the activity
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of proteases as adjuvants in allergic sensitisation [24–26].
However, even though it is well recognised that the bronchial
epithelium is a polarised structure, little is known about the
directionality of epithelial cytokine release. Vectorial cytokine
release may be critical for establishing concentration gradients of
certain cytokines that play key roles in chemoattraction and
immune cell recruitment.
Aside from their activity towards PARs, proteases can also
perturb the epithelial barrier by directly cleaving tight junction
proteins, facilitating permeation of allergens and pathogens to the
underlying tissue. Der p 1 can degrade occludin and trigger ZO-1
breakdown, resulting in tight junction disassembly and increased
paracellular permeability [27,28]; similar effects have also been
seen with HDM serine proteases [29]. The Penicillium allergen Pen
ch 13, a serine protease, has been reported to cleave occludin [30],
and effects on occludin, ZO-1, and claudin-1 have been noted
with serine and cysteine proteases in pollen from a variety of
sources [31].
Previous studies have focused on use of epithelial cell lines which
are not covered by a cytoprotective mucous layer that protects the
airways in vivo, which may explain their susceptibility to the
proteolytic effects of allergen-derived proteases. Furthermore, the
observation that there is impaired epithelial barrier function in
asthma [4] led us to investigate the effect of Alternaria on epithelial
barrier function, and to determine whether there is a differential
response to Alternaria extract between fully differentiated cultures of
primary human bronchial epithelial cells (PBECs) from healthy
donors and those from asthmatic donors. As Alternaria has been
observed to be both pro-inflammatory [16] and to induce
development of a Th2-type response [32,33], vectorial secretion
of IL-8, TNFa, thymic stromal lymphopoietin (TSLP), IL-18 and
IL-33 was analysed.
Methods
Ethics Statement
Ethical approval had been obtained from the Southampton
local research ethics committee under the description ‘‘Patho-
physiology of Airway Diseases such as Asthma and COPD’’, Rec.
No 05/Q1702/165, code MRC0268. All volunteers had provided
their written informed consent, and all samples were anonymous-
linked, with access to patient-identifiable data being available only
to those with prior ethical approval.
Cell Culture
The human bronchial epithelial cell-line, 16-HBE14o- (a gift
from Professor D.C. Gruenert, San Francisco, USA) [34] was
cultured in Minimal Essential Medium (MEM) with GlutaMax
supplemented with 10% heat-inactivated FBS, 50 IU/ml penicil-
lin and 50 mg/ml streptomycin (all Invitrogen, Paisley, UK). Cells
were placed in TranswellH culture inserts (Corning, Tewkesbury,
MA, USA) pre-coated with collagen I (Pure-Col, Nutacon BV,
Leimuiden, The Netherlands); they were used for experiment
when the transepithelial electrical resistance (TER) was.3000 V/
cm2. 24 h prior to challenge, 16HBE cells had the apical medium
replaced with serum-free MEM.
Primary bronchial epithelial cells (PBECs) were grown from
bronchial brushings obtained from non-asthmatic or severe
asthmatic volunteers by fibreoptic bronchoscopy, as previously
described [35] (for donor information, see Table S1). PBECs were
expanded in culture and, at passage 2, were taken to an air-liquid
interface (ALI) [4]. Cultures were used for assays at day 21 when
the TER was .3000 V/cm2. 24 h prior to challenge, the
basolateral medium of ALI cultures was replaced with BEBM
containing 1% ITS (Sigma-Aldrich, Gillingham, UK) and 1.5 mg/
ml BSA basolaterally.
Lyophilised Alternaria alternata and Cladosporium herbarum extracts
(Greer, Lenoir, NC, USA) were prepared by purification and
lyophilisation of fungal culture medium according to current Good
Manufacturing Practice to minimise inter-batch variability [36].
Extracts were dissolved into supplement-free medium and added
apically to cultures to achieve the desired concentrations. Protein
concentrations were 136 mg/mg dry weight for Alternaria extract
and 30 mg/mg dry weight for Cladosporium extract. LPS content
was not assayed, however, previous assays of the same product
have shown minimal endotoxin activity [32]; in view of the lack of
CD14 expression by epithelial cells [37], there is minimal
possibility that LPS contamination contributed to responses of
the BEC cultures. To assess heat-lability, fungal extracts were
heat-treated at 65uC for 30 min while the contribution of serine,
cysteine and aspartate protease activity was determined by
pretreating Alternaria extracts with AEBSF, E-64, or Pepstatin A
(Sigma-Aldrich, Gillingham, UK) respectively for 30 min imme-
diately prior to stimulation. To assess the contribution of p38
MAPK, SB203580 (Sigma-Aldrich) was added apically for 30 min
prior to challenge. At 24 h, apical and basolateral media were
harvested and cells were fixed for immunostaining. Further details
of cell culture and challenge can be found in Information S1.
Lactate Dehydrogenase (LDH) Assay
LDH release was measured using a CytoTox 96 LDH assay kit
(Promega, Southampton, UK) according to the manufacturer’s
instructions. Total cellular LDH activity was determined by lysing
cells with 1% Triton X-100 in culture medium for 60 min at 37uC.
FITC-Dextran Passage
FITC-dextran (4 kDa) was added to the apical compartment at
a final concentration of 2 mg/ml, 1h after the addition of the
fungal extracts. Basolateral FITC-dextran concentration at 24 h
was determined against a standard curve using a Labsystems
Fluoroskan FL fluorimeter (Thermo Fisher Scientific, Waltham,
MA), with excitation and emission wavelengths set to 485 nm and
530 nm respectively.
Cytokine Analysis
Release of IL-8, TNFa, IL-18 and IL-33 into the apical and
basolateral compartments was assayed by ELISA according to the
manufacturer’s instructions (R&D Systems, Abingdon, UK). For
assay of TNFa release from ALI cultures, a high-sensitivity TNFa
ELISA kit (R&D Systems) was used. TSLP was measured using an
‘in-house’ ELISA developed by Novartis Plc (Horsham, UK),
which recognises both E. coli expressed recombinant TSLP and
naturally secreted TSLP from primary lung fibroblasts.
Detection of Protease Activity
Alternaria extract protease activity was assessed using a protease
fluorescent detection kit (Sigma-Aldrich) according to the manu-
facturer’s instructions. This kit was also used to measure attenuation
of Alternaria protease activity by prior heat-treatment of the extract or
the protease inhibitors AEBSF, E-64, or Pepstatin A.
Statistical Analysis
Results were analysed by one-way repeated measures ANOVA
with Bonferroni’s correction for pairwise analyses, or a ranked
version thereof (Friedman Repeated Measures ANOVA), with
Bonferroni’s or Tukey’s correction for pairwise analyses, as
Effects of Alternaria on Bronchial Epithelium
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appropriate. All analyses were performed using SigmaPlot 11.0
(Systat Software, Hounslow, UK).
Results
The Effect of Alternaria Extracts on Inflammatory
Mediator Release by 16HBE Cells
Polarised 16HBE cells were challenged with Alternaria extract,
and cytokine release after 24 h stimulation was measured by
ELISA. Alternaria induced a dose-dependent increase in apical IL-8
release (Figure 1A), with 100 mg/ml Alternaria (Alt100) significantly
inducing IL-8 release compared with untreated controls, or cells
treated with heat-treated Alt100 (Alt100HT) or 100 mg/ml
Cladosporium extract (Clad100). While Alt100 also induced a
significant increase in basolateral IL-8 release compared to control
(Figure 1B), this was less marked than apical release. Clad100 did
not increase basolateral IL-8 release above baseline and heat
treatment of the Alternaria extract (Alt100HT) tended to reduce the
stimulation of basolateral IL-8 release, but this failed to reach
statistical significance. Analysis of TNFa release after Alternaria
challenge revealed similar results to IL-8 analysis (Figure S1).
The Effect of Alternaria on 16HBE Transepithelial
Electrical Resistance
We next investigated the effect of Alternaria on TER. A
significant dose-dependent decrease in TER was observed 1h
post-challenge with both Alt50 and Alt100 (Figure 1C). With
Alt50, the drop in TER began to recover almost immediately,
particularly from 3 h onwards, reaching control levels by 6 h
(Figure S2). After challenge with Alt100, the TER remained
significantly lower than control, even 24 h post-challenge
(Figure 1D). As found with cytokine release, Alt100HT showed
no significant effect on TER at any time point. Similarly, Clad100
did not affect TER. The dose-dependent, heat-labile increase in
epithelial permeability caused by Alternaria extracts was confirmed
by studies with FITC-labelled 4 kDa dextran (Figure S3),
suggesting that Alternaria affects both ionic and macromolecular
permeability; however the extent to which passage of the 4 kDa
macromolecule was facilitated by exposure of the epithelium to
Alternaria was small compared to the effect of the calcium chelator
EGTA (50 mM). None of the challenges significantly induced
LDH release compared with control cultures (data not shown).
Protease Activity of Alternaria Extract
To determine specific protease activity in Alternaria extract, a
fluorescent protease assay was performed in the presence of a
variety of protease inhibitors (Figure 2). The serine protease
inhibitor AEBSF significantly reduced the protease activity of
Alternaria extract whereas the aspartate protease inhibitor Pepstatin
A had a small effect, and the cysteine protease inhibitor E-64 had
no effect. Heat-treatment of Alternaria extract reduced protease
activity to below the detection limit of the assay. No inhibitor
possessed intrinsic proteolytic activity.
Figure 1. Alternaria extract induces a heat-labile increase in IL-8 release and rapid reduction in TER in polarised 16HBE cells. Polarised
16HBE cells on Transwell inserts were challenged apically with varying doses of Alternaria (Alt) or Cladosporium (Clad) fungal extracts, or heat treated
fungal extract. (A) Apical and (B) basolateral supernatants were harvested 24 h post-challenge. IL-8 concentration was determined by ELISA (n = 4–9).
TER was measured before challenge and at (C) 1h and (D) 24 h thereafter, and calculated as percentage change from pre-challenge readings (n = 4–
15). Bars represent mean 6 SEM. Analysis by one way repeated measures ANOVA with Bonferroni correction for pairwise analyses *** p,0.001.
doi:10.1371/journal.pone.0071278.g001
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The Effect of Protease Inhibitors on Proinflammatory
Cytokine Release
To examine whether protease activity contributed to the effect of
Alternaria on the epithelial cells, Alt100 was pre-incubated with
protease inhibitors prior to challenge of the epithelial cultures;
control cultures were tested in the presence of inhibitor alone. Apical
release of IL-8 in response to Alt100 was not significantly affected by
any of the protease inhibitors; in contrast both AEBSF and Pepstatin
A significantly reduced basolateral IL-8 release (Figure 3). As we
failed to affect apical cytokine release with protease inhibitors, we
also tested the effect of inhibiting p38 MAPK which we have
previously found to inhibit pollen-induced apical IL-8 release,
without affecting transcription [38]. Correspondingly, the present
data shows SB203580 significantly reduced apical IL-8 release while
not significantly affecting basolateral cytokine release. Neither apical
nor basolateral release of TNFawere significantly affected by any of
the inhibitors tested (Figure S4).
The Effect of Protease Inhibitors on the Permeabilising
Activity of Alternaria
To further explore the effect of protease inhibition, TER changes
were investigated using Alt100 pre-treated with the same inhibitors.
At 1h post-challenge, either E-64 or SB203580 significantly
inhibited the decrease in TER caused by Alternaria (Figure S5). At
24 h post-challenge, while inter-treatment differences approached
significance, the significance threshold was not crossed. However,
there was a notable attenuation of the effect of Alternaria on TER
after incubation with either AEBSF or Pepstatin A.
The Effect of Alternaria on Polarised Cytokine Release
from ALI Cultures
Having observed significant effects of Alternaria using the 16HBE
bronchial epithelial cell line, experiments were performed using
primary epithelial cells differentiated at an ALI. For these
experiments, cells were derived from non-asthmatic and severe
asthmatic donors allowing disease-related comparisons to be
made. Preliminary studies showed that higher concentrations of
Alternaria were required to elicit responses in ALI cultures
compared to 16HBE, and therefore up to 400 mg/ml was used.
In ALI cultures from healthy donors, the highest dose of
Alternaria (Alt400) significantly induced an approximate doubling of
IL-8 release apically versus heat-treated Alternaria (Figure 4).
Alternaria also tended to cause a dose-dependent increase in
basolateral release of IL-8, significant for Alt400 with IL-8 levels
eight-fold higher than control. Cladosporium extract had no
significant effect on IL-8 release. Thus, basolateral IL-8 release
tended to be more responsive to Alternaria than was apical IL-8
release (see Figure S6), the reverse of the situation seen in 16HBE
cells, although the degree of inter-donor variability makes it
difficult to draw robust conclusions regarding this directionality.
When the same experiments were performed on ALI cultures from
severely asthmatic donors, none of the challenges elicited a
significant increase in release of IL-8 into either compartment
(Figure 4). TNFa levels were generally below the lower detection
limit (0.5 pg/ml) of the high-sensitivity ELISA kit.
Given the previous association of Alternaria with development of
a Th2 phenotype [32,33,39], we also assessed release of IL-18, IL-
33, and TSLP by ALI cultures after exposure to Alternaria. Using
commercially available ELISA kits, these cytokines were unde-
tectable (lower limit of detection = 10.2 pg/ml) in either apical or
Figure 2. Protease activity of Alternaria extract is reduced by
the serine protease inhibitor AEBSF. FITC-labelled casein was
incubated with Alternaria extract (500 mg/ml) alone or in the presence
of either AEBSF (2.5 mM), E-64 (500 mM), Pepstatin A (5 mg/ml), or heat-
treated (n = 4 separate experiments measured in duplicate). Soluble
fluorescence was measured after 24 h, relative to a trypsin standard.
Bars represent mean fluorescence relative to inhibitor-free control6-
SEM. Protease activity of 100 mg/ml Alternaria extract was equivalent to
6.762.5 mg/ml trypsin; for comparison, Cladosporium protease activity
was equivalent to 3.360.0 mg/ml trypsin. Analysis as for Figure 1. Bars
represent mean 6 SEM; *** p,0.001.
doi:10.1371/journal.pone.0071278.g002
Figure 3. Inhibitors of proteases and p38 MAPK differentially
inhibit apical and basolateral IL-8 release after Alternaria
challenge. The effect of Alternaria extract (100 mg/ml) on 16HBE cells
was tested alone or in the presence of AEBSF (250 mM), E-64 (50 mM),
Pepstatin A (0.5 mg/ml) or SB203580 (25 mM) (n = 3–8). IL-8 release 24 h
post-challenge was calculated as ‘‘Release (% control) = ((AltINHIB – No
AltINHIB)/(AltNO INHIB – No AltNO INHIB))6100’’, to correct for any effect of
the inhibitors on baseline IL-8 release without Alternaria. Data show
mean 6 SEM. Analysis as for Figure 1; * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0071278.g003
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basolateral supernatants across all groups. However, using an ‘in-
house’ TSLP ELISA, basolateral TSLP release was detectable but
there was no significant difference in TSLP secretion comparing
untreated or Alternaria-stimulated ALI cultures from either healthy
or severe asthmatic donors (Figure S7). No apical secretion of
TSLP was detectable.
The Effect of Alternaria on ALI Culture Transepithelial
Electrical Resistance
In ALI cultures from healthy donors, Alternaria had no effect on
TER after 3 h (Figure 5). By 24 h, TERs in the healthy donor
ALIs were all increased to 8–14% of their baseline levels, with no
difference between challenges. In contrast, cultures derived from
severely asthmatic donors responded to Alternaria challenge with a
rapid dose-dependent decrease in TER at 3 h compared to control
and heat-treated Alternaria. By 24 h post-challenge, no difference
existed between treatments. These results suggest that, unlike ALI
cultures from healthy donors, asthmatic donor ALI cultures are
susceptible to a rapid loss of epithelial barrier function after
exposure to Alternaria. The heat lability of this effect suggests that it
is protease-mediated.
Discussion
This study investigated the potential of Alternaria proteases to
perturb airway epithelial barrier function using cultures that are
fully differentiated and covered by a layer of cytoprotective mucus
as occurs in vivo, and to determine whether these responses are
different in severe asthma. Our main findings were that ALI
cultures from severely asthmatic donors exhibited a more variable
IL-8 response to Alternaria extracts relative to those from healthy
donors, while only cultures from severely asthmatic donors were
susceptible to the barrier-weakening effects of Alternaria. Further-
more, while previous studies with cell lines have suggested that
exposure to Alternaria extracts leads to production of cytokines that
promote a Th2 response [33,39], we failed to detect any epithelial
release of IL-33 or IL-18, while basolateral TSLP secretion did not
change in response to Alternaria.
Induction of inflammation has previously been shown to occur
upon challenge with serine proteases from Aspergillus fumigatus [15]
and Alternaria [40,41]. However, these studies did not take into
account epithelial polarisation, and were thus unable to study the
directionality of cytokine release, which is important in the context
of establishing a chemotactic gradient for IL-8 to act as a
neutrophil chemoattractant [42–45]. The results of this study also
emphasise the importance of cell differentiation since Alternaria-
induced release of IL-8 and TNFa was predominantly apical for
undifferentiated 16HBE cells, whereas for differentiated ALI
cultures the greatest fold stimulation was observed for the
basolateral compartment (median 2.9 fold apical versus 7.1 fold
basolateral in healthy donor cultures). Also of note is the
observation that TSLP is exclusively released into the basolateral
Figure 4. ALI cultures of healthy, but not severely asthmatic, donors increase IL-8 release in response to Alternaria. ALI cultures from
healthy (n = 8–12) or severely asthmatic (n = 6–7) donors were differentiated at air-liquid interface, prior to challenge with Alternaria (Alt) or
Cladosporium (Clad) fungal extracts. IL-8 release 24 h post-challenge was determined by ELISA. Box shows median and 25th/75th percentiles, and
whiskers show 10th/90th percentiles. Analysis by Friedman’s test with Tukey’s correction for pairwise analyses; * p,0.05.
doi:10.1371/journal.pone.0071278.g004
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compartment highlighting the importance of epithelial polarisation
for vectorial cytokine secretion. This may be significant in terms of
establishing appropriate concentration gradients for chemoattrac-
tants that direct cells to the luminal or subepithelial compartments.
Although Alternaria-stimulated IL-8 release into the basolateral
compartment was relatively small, this stimulatory effect was
greatly inhibited by AEBSF and Pepstatin A suggesting a protease-
mediated effect. Conversely, protease inhibition failed to affect
apical IL-8 release, which was instead sensitive to inhibition of p38
MAPK which is thought to play a role in stabilising IL-8 mRNA
[46]. Although it has been well established that some growth
factors are selectively sorted to the basolateral surface via
information that usually resides in the cytoplasmic tail of the
cargo [47], this does not explain how trafficking of a protein such
as IL-8 is differentially regulated towards the apical or basolateral
domains. Although this question has not been explored in detail,
we have recently shown that trafficking of IL-8 in ALI cultures
challenged with grass pollen extract is post-transcriptionally
regulated with apical release being selectively regulated by p38
MAPK [38] as observed in the present study using Alternaria. While
the PAR-2 agonist trypsin, as well as a PAR-2 activating peptide,
have been shown to activate p38 MAPK expression weakly, it
seems unlikely that PAR-2 activation lies upstream of p38 MAPK
activation in mediating Alternaria-induced apical IL-8 release as this
response was insensitive to protease inhibitors.
Although HDM serine and cysteine proteases have been
reported to increase epithelial permeability [27,29], there is a
paucity of comparative studies of fungal proteases, particularly
using Alternaria. The present study suggests that heat labile
activities in Alternaria extracts significantly and rapidly weaken
the epithelial barrier, initially due to cysteine protease activity, and
also via a p38 MAPK-mediated mechanism. However, both E-64
and SB203580 exhibited non-specific barrier-weakening effects at
the 1h time point, and this may be a factor in the apparent
reduction of activity of Alternaria in this respect. At 24 h a lesser
degree of non-specific barrier-weakening activity was displayed by
the inhibitors, and serine and aspartate protease inhibition
appeared to show a trend for inhibition of the reduction in TER
caused by Alternaria.
Fungal proteases fulfil a number of functions, particularly the
external digestion of macronutrients, but are also intrinsic to the
pathogenesis of diseases resulting from fungal exposure [48].
Taken together, these results suggest that the effects of Alternaria at
the airway epithelium are due to serine and, to a lesser extent,
aspartate protease activity, with the involvement of proteases in
general being supported by the lack of activity of heat-treated
Alternaria extract. Recent reports have suggested a role for serine
and aspartate proteases in the cellular effects of Alternaria but, to
our knowledge, this is the first work which suggests that both
classes of protease exert significant effects. For example, it has
been suggested that the active component(s) of Alternaria in the
induction of proinflammatory responses in bronchial epithelial
cells is serine protease(s) acting on PAR-2 [40], although this has
not been confirmed in vivo [49]. In contrast, it has been suggested
recently that the actions of Alternaria on epithelial cells and
eosinophils are sensitive to aspartate protease inhibition, but not to
serine protease or cysteine protease inhibition [50–52]. In our
studies, serine proteases were the dominant activity in the protease
assays, although inhibition of either serine or aspartate protease
activity had a potent suppressive effect on IL-8 release. This
discrepancy may be explained by the relative sensitivity of the
fluorescent assay for serine and aspartate proteases or alternative-
ly, it is possible that the effect of Pepstatin A on IL-8 release may
be due, in part, to inhibition of endogenous proteases. For
example, it has been reported that challenge of epithelial cells with
Aspergillus fumigatus triggers release of lysosomal enzymes including
the aspartate protease, cathepsin D [53], which may affect
subsequent cytokine responses. In addition to proteases, other
constituents of Alternaria extract such as b-glucans and chitin (cell
wall components) have been noted to exert immunomodulatory
effects [54–56]. However, the lack of residual effect after heat-
treatment of Alternaria in the present study suggests that the effect
of b-glucans was negligible in our studies, although we cannot
exclude the effect of other unidentified components, either
proteinaceous or small molecules, which may be affected by heat
treatment.
The study was then extended to examine primary bronchial
epithelial cells in ALI cultures, as a more accurate model of human
airway exposure. ALI cultures from non-asthmatic donors
exhibited increased IL-8 release in response to Alternaria, while
responses of cultures from asthmatic donors exhibited a trend of
being blunted and not statistically significant, although consider-
able inter-individual variability was observed.
ALI cultures from healthy donors were resistant to the increase
in epithelial permeability seen when ALI cultures from severely
asthmatic donors were challenged with Alternaria. To our
knowledge, this is the first study which has examined differential
responses to Alternaria between healthy and asthmatic ALI cultures.
The implications are potentially significant: if the permeability of
the bronchial epithelium in asthma is significantly increased by
Alternaria, passage of inhaled allergens to the subepithelial tissue
may be facilitated, and epithelial homeostasis disrupted. Since ALI
Figure 5. ALI cultures from severely asthmatic donors are
sensitive to the barrier weakening effect of Alternaria. ALI
cultures from healthy (grey bars; n = 7–9) and severely asthmatic (black
bars; n = 6–7) donors were challenged with Alternaria (Alt) or
Cladosporium (Clad) fungal extracts. TER was measured pre-challenge
and 3 h and 24 h post-challenge. Results are expressed as percentage
change in TER relative to pre-challenge and are shown as mean 6 SEM.
Analysis as for Figure 1; * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0071278.g005
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cultures from asthmatic donors also displayed a lack of response to
Alternaria in terms of IL-8 secretion, the ability to upregulate
recruitment of neutrophils and clearance of allergens and toxicants
in response to Alternaria may be affected. This impaired response of
the epithelial cells from asthmatic donors to Alternaria is unlikely to
be due to carry-over of corticosteroids used for asthma control
therapy, as we have shown that similar ALI cultures respond to
pollen extract with a significant increase in IL-8 release
irrespective of whether they were derived from healthy or severely
asthmatic donors [38].
Using commercially available ELISA kits, we failed to detect any
IL-18, IL-33 or TSLP release by the ALI cultures. IL-33 release has
been shown to be increased by Alternaria in murine BAL fluid and in
normal human bronchial epithelial cells (NHBE) [33], however in
the latter case the epithelial cell cultures were undifferentiated. In
contrast, others have failed to detect IL-33 or TSLP secretion from
either NHBEs challenged with Alternaria [39] or mouse lung
epithelial cells challenged with Aspergillus fumigatus [56]. We also
failed to detect IL-18, despite a recent report of a marked rapid
release of IL-18 after Alternaria challenge of NHBE cells [39].
However, control experiments performed in our laboratory and
assayed at the same time showed IL-18 and TSLP production in
response to rhinovirus challenge (data not shown), suggesting that
the lack of any observable effect with Alternaria was not due to
defective epithelial synthesis or release of these mediators. Although
we initially failed to detect TSLP with a commercial ELISA (from
R&D Systems), use of an alternative ‘in-house’ ELISA (developed by
Novartis plc.) enabled detection and quantification of basolateral
TSLP release, however no apical secretion was evident. We
postulate that this difference in detection is due to differences in
antibody recognition of recombinant and native TSLP, making the
commercial ELISA kit much less sensitive for detection of the
naturally produced protein. Having observed such a large difference
in sensitivity for detection of TSLP, it is possible that the ELISAs
employed for measurement of IL-33 and IL-18 may also be similarly
compromised.
TSLP is secreted by epithelial cells and potently activates
human dendritic cells to release a battery of cytokines which results
in Th2-skewing of naı¨ve CD4+ T cells [57]. Alternaria has been
shown to increase TSLP expression and release from airway
epithelial cells in vitro via PAR-2 activation [26]. However, even
though we were confident in our ability to detect TSLP reliably,
we found no significant change in TSLP release in response to
Alternaria. One likely explanation is the use of fully differentiated
ALI cultures in the present work, as opposed to undifferentiated
monolayers in the previous studies, emphasising the importance of
using models that closely mimic the in vivo state. While there is
strong evidence to suggest that Alternaria exposure can induce Th2-
type responses in vivo, and that TSLP released from structural cells
can act as a potent mediator for Th2 skewing [58], it is possible
that epithelial cells require the presence of other cell types or
multiple stimuli for Alternaria to have such an effect. For example,
IL-4 and double-stranded RNA potently synergise to stimulate
TSLP release from bronchial epithelial cells in vitro [59].
In summary, this study demonstrates that Alternaria extract is
able to significantly induce release of inflammatory cytokines and
to increase the permeability of a polarised airway epithelial cell
line. These effects were attributed to a heat-labile component of
the Alternaria, identified as being serine and possibly aspartate
protease mediated. Crucially, this study is the first to demonstrate
that fully differentiated epithelial cultures from asthmatic donors
appear to have a blunted IL-8 response to high levels of Alternaria,
while at the same time being more susceptible to the barrier-
weakening effect of Alternaria, than those from healthy donors.
Supporting Information
Figure S1 Alternaria extract induces a heat-labile
increase in TNFa release from polarised 16HBE cells.
Polarised 16HBE cells on Transwell inserts (n = 3–9) were
challenged apically with Alternaria (Alt) or Cladosporium (Clad)
fungal extracts. Apical and basolateral supernatants were harvest-
ed 24 h post-challenge. TNFa concentration was determined by
ELISA. Analysis by one way repeated measures ANOVA with
Bonferroni correction for pairwise analyses. Bars represent mean
6 SEM; ** p,0.01; *** p,0.001.
(TIF)
Figure S2 Alternaria extract induces a dose-dependent
decrease in 16HBE TER. TER was measured before fungal
challenge of polarised 16HBE cells, and at regular intervals up to
24 h thereafter (n = 4–15). Graph shows TER of polarised 16HBE
cultures in medium alone (m), or with Alternaria extract at 50 (N) and
100 ml/ml (¤), expressed as percentage change from pre-challenge
value. Points represent mean 6 M.
(TIF)
Figure S3 Alternaria extract increases epithelial mac-
romolecular permeability. Polarised 16HBE cells on Trans-
well inserts were challenged with medium, Alt50, Alt100 (all n = 4),
Alt100HT, Clad100, or EGTA (n = 2) 1 h before addition of
2 mg/ml 4 kDA FITC-dextran. After 24 h challenge, basolateral
FITC-dextran concentration was determined fluorimetrically.
Analysis as for Figure S1 Bars represent mean 6 SEM; ** p,0.01.
(TIF)
Figure S4 Inhibitors of proteases and p38 MAPK have
no significant effect on apical or basolateral TNFa
release after fungal challenge. The effect of Alternaria
(100 mg/ml) on 16HBE cells was tested alone or in the presence
of AEBSF (250 mM), E-64 (50 mM), Pepstatin A (0.5 mg/ml) or
SB203580 (25 mM) (n = 3–8). TNFa release 24 h post-challenge
was calculated as ‘‘Release (% control) = ((AltINHIB – No
AltINHIB)/(AltNO INHIB – No AltNO INHIB))6100’’, to correct for
any effect of the inhibitors on baseline TNFa release without
Alternaria. Analysis as for Figure S1. Data show mean 6 SEM.
(TIF)
Figure S5 Alternaria-induced drop in TER is sensitive
to inhibition of cysteine protease and p38 MAPK. The
effect of Alternaria (100 mg/ml) on 16HBE cells was tested alone or
in the presence of AEBSF (250 mM), E-64 (50 mM), Pepstatin A
(0.5 mg/ml) or SB203580 (25 mM) (n = 3–6). TER was measured
at 1 h and 24 h post-challenge, calculated as percentage change
from pre-challenge, and corrected for any effect of the inhibitor
alone by subtracting the percentage change in TER in the absence
of Alternaria from the percentage change in TER in the presence
of Alternaria, with each respective inhibitor or inhibitor-free
condition. Bars represent mean change 6 SEM; ** p,0.01.
(TIF)
Figure S6 The increase in IL-8 release in healthy donor
ALI cultures is driven by increased basolateral release of
IL-8. ALI cultures from healthy (n = 8–12) or severely asthmatic
(n = 6–7) donors were differentiated at air-liquid interface, prior to
challenge with Alternaria (Alt) 400 mg/ml. IL-8 release 24 h post-
challenge was determined by ELISA. Lines represent difference in
individual donor cultures between control and Alt400-stimulated
IL-8 release. Analysis by Wilcoxon Matched Pair test. ***
p,0.001.
(TIF)
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Figure S7 Alternaria challenge does not affect basolat-
eral release of TSLP in healthy or severely asthmatic
donor ALI cultures. ALI cultures from healthy (n = 7–12) or
severely asthmatic (n = 6–7) donors were differentiated at air-liquid
interface, prior to challenge with Alternaria (Alt) or Cladosporium
(Clad) fungal extracts. TSLP release 24 h post-challenge was
determined by ELISA. TOP: Boxes show median and 25/75th
percentiles, and whiskers show 10th/90th percentiles. Analysis by
Friedman’s test. BOTTOM: Lines represent difference in
individual donor cultures between control and Alt400-stimulated
TSLP release.
(TIF)
Information S1
(DOCX)
Table S1 PBEC donor information. Clinical characterisa-
tion of the donors of the bronchial epithelial cells used in this work.
FEV1% – forced expiratory volume in 1 second, as a percentage of
predicted value; ICS – inhaled corticosteroid (dose as equivalent to
micrograms per day Beclometasone dipropionate); LABA = long
acting b2-adrenoceptor agonist; anti-leuk = anti-leukotriene.
(DOCX)
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